Form 4: Organogenesis Holdings Inc. Executive Reports Stock Disposals

Antonio S. Montecalvo, Vice President of Health Policy at Organogenesis Holdings Inc., reports the disposal of Class A Common Stock to cover tax obligations.

Summary

• Antonio S. Montecalvo, Vice President, Health Policy at Organogenesis Holdings Inc., filed a Form 4 detailing changes in beneficial ownership.
• The report indicates the disposal of Class A Common Stock on February 15, 2025, and February 16, 2025.
• These disposals were likely to cover tax obligations, as indicated by transaction code 'F'.
• The price per share for these transactions was $3.7.
• Following these transactions, Montecalvo directly owns 154,187 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock disposals likely related to tax obligations, which is a routine event.

Risks

• Executive stock disposals can sometimes be perceived negatively by investors, although in this case it appears to be for tax obligations.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• The disposal of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the likely reason for the disposal.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Disposal, Organogenesis Holdings Inc., ORGO, Antonio S. Montecalvo, Executive Compensation, Health Policy